Oppenheimer Cuts Xylem (XYL) Price Target to $150

Oppenheimer has reiterated its Outperform rating on Xylem Inc. (NYSE: XYL) and set a new price target of $150, down from $158, on October 14, 2026. This new target reflects Oppenheimer's continued confidence in the company's growth potential.

As of October 16, 2026, Xylem's stock was recently trading around $103.68, which is about 30.9% below Oppenheimer's target. This position may present a buying opportunity for some investors, especially considering the company's solid fundamentals.

Other Institutional Activity in Xylem

Several other institutional investors have made adjustments to their holdings in Xylem. Blackrock Inc. reduced its stake by 615,686 shares, leaving it with about 25.04 million shares valued at approximately $2.61 billion. Vanguard Capital Management LLC also trimmed its position, cutting 283,116 shares for a total of about 15.53 million shares worth around $1.62 billion. Meanwhile, Vanguard Portfolio Management LLC decreased its holdings by 151,973 shares, ending with approximately 12.62 million shares valued at about $1.31 billion. On the other hand, State Street Corporation increased its stake by 271,508 shares, bringing its total to about 11.44 million shares worth around $1.19 billion.

Xylem Inc. Stock Down 3.6%

Xylem's shares are currently trading below the new price target of $150, suggesting a potential disconnect between market perception and analyst expectations. The recent price of $103.68 indicates that the stock might be undervalued based on Oppenheimer's outlook. This contrasts with its recent performance, as the company has experienced stable revenue growth.

Recent Earnings

Xylem reported trailing twelve-month revenue of approximately $9.13 billion, reflecting a year-over-year growth of 1.5%. The company also has an EPS of $4.19, with a net margin of 11.2% and a return on equity of 9.2%. Investors should note that Xylem is scheduled to announce its next earnings on November 3, 2026.

Dividend

Xylem pays an annual dividend of $1.72 per share, resulting in a yield of about 1.7%. The dividend payout ratio stands at 39.5%, indicating a balanced approach to returning value to shareholders while investing in growth.

Insider Buying and Selling at Xylem Inc.

In recent insider transactions, Jerome A Peribere, a director at Xylem, bought 1,210 shares at an average price of $116.61 on May 4, 2026, totaling about $141,098. Meanwhile, Victoria D Harker, also a director, sold 1,700 shares for approximately $251,838 on November 4, 2025. Geri-Michelle Mcshane, an officer, sold 4,269 shares at $117.46 for a total of about $501,437 on May 7, 2026.

Analysts Set New Price Targets

On October 5, 2026, UBS maintained a Neutral rating on Xylem with a price target of $112, down from $138. Citigroup also maintained a Buy rating with a target of $148, reduced from $172 on October 12, 2026. Barclays kept an Overweight rating with a target of $139, down from $159 on October 13, 2026. Oppenheimer's recent target of $150 aligns with a generally cautious outlook among analysts, reflecting broader market conditions.

About Xylem

Xylem Inc. designs and manufactures products and solutions focused on water management for utility, industrial, and building services settings. With a dedicated workforce of about 22,000 employees, the company plays a crucial role in providing engineered solutions that address water issues worldwide. This latest analyst call comes as Xylem continues to navigate a complex industrial landscape while maintaining its commitment to innovation and sustainability.

Bottom Line

Investors should keep an eye on Xylem's upcoming earnings announcement on November 3, 2026, as it could provide further insight into the company's performance and outlook. With Oppenheimer's reiteration of the Outperform rating, there may be more developments to watch in the coming weeks.